Your session is about to expire
← Back to Search
Dietary Supplement
Very Low Calorie Diet for Non-alcoholic Fatty Liver Disease
Phase 1
Recruiting
Led By Marcelo L Correia, MD PhD
Research Sponsored by University of Iowa
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
BMI ≥ 30 kg/m2 and ≤ 50 kg/m2
Male and female subjects with age ≥ 18 years old and < 70 years old
Must not have
Porphyria
Coexisting liver disease or end-stage liver disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether a very low-calorie diet can help improve non-alcoholic fatty liver disease (NAFLD) by reducing liver steatosis (fatty infiltration) and fibrosis (scarring). If successful, this could establish the diet as a clinically effective option for treating NAFLD, particularly for patients who are ineligible or don't have access to bariatric surgery.
Who is the study for?
This trial is for adults aged 18-70 with obesity (BMI between 30 and 50) and non-alcoholic fatty liver disease, confirmed by imaging or specific elastography scores. Participants must not have viral hepatitis, autoimmune hepatitis, uncontrolled thyroid issues, severe alcohol use, certain heart conditions, type 1 diabetes or insulin-using type 2 diabetes, significant kidney disease or other serious health problems.
What is being tested?
The study tests if a very low calorie diet (VLCD), which limits intake to about 800-960 calories per day through meal replacements, can reduce fat and fibrosis in the liver compared to a lower calorie diet. The effects on micro RNAs related to NAFLD pathophysiology will also be explored.
What are the potential side effects?
Potential side effects of VLCD may include fatigue due to energy deficit; nutrient deficiencies if not properly managed; digestive changes like constipation; gallstones from rapid weight loss; and possible mood swings or irritability.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My BMI is between 30 and 50.
Select...
I am between 18 and 70 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have porphyria.
Select...
I have liver disease or my liver is failing.
Select...
My thyroid is overactive and not controlled by medication.
Select...
I need oxygen therapy for my COPD.
Select...
I have heart failure.
Select...
My kidney function is very low.
Select...
I have had or currently have gallbladder inflammation and have not had my gallbladder removed.
Select...
I have unstable chest pain.
Select...
I have had kidney stones made of uric acid before.
Select...
I have gout.
Select...
I have Type 1 diabetes.
Select...
I have type 2 diabetes and use insulin.
Select...
I am taking warfarin, lithium, or prednisone (20mg or more daily).
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 8 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Liver fibrosis
Liver steatosis
Secondary study objectives
Fecal microbiome
Micro RNA (miRNA)
Platelet function
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Very Low Calorie Diet ArmExperimental Treatment1 Intervention
We plan to perform a controlled, non-randomized, open-label, pilot clinical trial to evaluate the effect of an 8-week VLCD intervention on NAFLD.
Group II: Control ArmExperimental Treatment1 Intervention
The control group will consume a lower calorie diet and will be instructed to reduce their usual intake of normally consumed foods by up to 500 kcal per day but no less than 1200 kcal per day.
Find a Location
Who is running the clinical trial?
University of IowaLead Sponsor
466 Previous Clinical Trials
893,371 Total Patients Enrolled
Marcelo L Correia, MD PhDPrincipal InvestigatorUniversity of Iowa
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have porphyria.I have had a heart attack in the last 6 months.My thyroid is overactive and not controlled by medication.I need oxygen therapy for my COPD.I have heart failure.My kidney function is very low.I have had or currently have gallbladder inflammation and have not had my gallbladder removed.I have unstable chest pain.My BMI is between 30 and 50.I have signs of fatty liver on an ultrasound, CT scan, MRI, or my elastography score is F1 or higher/S1 or higher.I have liver disease or my liver is failing.You are trying to get pregnant, already pregnant, or currently breastfeeding.I have had kidney stones made of uric acid before.I have gout.I am between 18 and 70 years old.I have Type 1 diabetes.I have type 2 diabetes and use insulin.You have a serious or uncontrolled mental health condition, like an eating disorder.I am taking warfarin, lithium, or prednisone (20mg or more daily).
Research Study Groups:
This trial has the following groups:- Group 1: Control Arm
- Group 2: Very Low Calorie Diet Arm
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger